B. Saxena
B. Saxena publishes mostly in Psychiatry and Mental health, Pharmacology and Clinical Psychology, on topics such as Treatment of Major Depression, Schizophrenia research and treatment and Electroconvulsive Therapy Studies.
- World rank
- #6,677,233 of 7,710,434 ranked researchers
- Rank in Canada
- #174,891 of 183,316
- Works
- 38
- Citations
- 397
- Citations per work
- 10.4
What does B. Saxena research?
B. Saxena's work is mostly in Medicine (51%), Psychology (8%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1950.6%
- Medicine1950.6%
- Everything else924.1%
- Life Sciences411.4%
- Social Sciences37.6%
- Psychology37.6%
- Physical Sciences26.3%
- Chemistry26.3%
- 1Psychiatry and Mental health35% of their works
- 2Pharmacology15% of their works
- 3Clinical Psychology8% of their works
- 4Organic Chemistry6% of their works
- 5Molecular Biology6% of their works
- 6Cellular and Molecular Neuroscience5% of their works
Research topics
- Treatment of Major Depression
- Schizophrenia research and treatment
- Electroconvulsive Therapy Studies
- Bipolar Disorder and Treatment
- Attention Deficit Hyperactivity Disorder
- Neurotransmitter Receptor Influence on Behavior
- Pharmacological Effects and Toxicity Studies
- Child and Adolescent Psychosocial and Emotional Development
Which keywords describe B. Saxena's research?
The keywords of their largest research topics: Depression, Antidepressant, Ketamine, Neurobiology, Prevalence, Cognitive Function, Antipsychotic Drugs and Electroconvulsive Therapy.
- Psychopathology
- Emotion Regulation
- Serotonin
- Attention-Deficit/Hyperactivity Disorder
- Treatment Guidelines
- Serotonin Syndrome
- Electroconvulsive Therapy
- Cognitive Function
- Neurobiology
- Antidepressant
- Depression
- Ketamine
- Prevalence
- Antipsychotic Drugs
- Neurocognitive Deficits
- Bipolar Spectrum Disorder
- ADHD
- Dopamine
- Antiepileptic Drugs
- Prenatal Exposure
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Depression223 topics
- Antidepressant121 topic
- Ketamine121 topic
- Neurobiology112 topics
- Prevalence112 topics
- Cognitive Function92 topics
- Antipsychotic Drugs71 topic
- Electroconvulsive Therapy71 topic
- Neurocognitive Deficits71 topic
- Serotonin Syndrome71 topic
- Bipolar Spectrum Disorder61 topic
- Treatment Guidelines61 topic
- ADHD51 topic
- Attention-Deficit/Hyperactivity Disorder51 topic
- Dopamine41 topic
- Serotonin41 topic
- Antiepileptic Drugs31 topic
- Emotion Regulation31 topic
- Prenatal Exposure31 topic
- Psychopathology31 topic
Where does B. Saxena work?
B. Saxena's main affiliation in the publication record is Douglas College, Canada.
How many publications and citations does B. Saxena have?
OpenAlex counts 38 works and 397 citations for B. Saxena, an h-index of 12, ranking #6,677,233 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about B. Saxena. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.